高收入国家结核病患者住院管理现状:一项回顾性队列研究
日本东京一家三级医疗中心2012至2017年回顾性纳入448例成人结核住院患者,院内死亡率为16.7%(75/448),粟粒性/播散性结核占13.2%(59/448)。多因素分析显示,入院时低Karnofsky功能状态评分、年龄超过89岁、Charlson合并症指数>5、发生任何医疗保健相关感染以及发生导致停用抗结核药物的药物相关不良事件与院内死亡独立相关。
要点
- 入院Karnofsky评分40-10者院内死亡风险显著升高(aOR 25.65)。
- 发生医疗保健相关感染与院内死亡独立相关(aOR 2.95)。
- 药物相关不良事件致停用抗结核药与院内死亡相关(aOR 2.29)。
核心结论
- 院内不良事件(医疗保健相关感染和药物相关不良事件)以及患者相关变量与结核患者院内死亡相关。
研究设计与样本
- 2012至2017年在日本东京一家三级医疗中心开展的回顾性队列研究,纳入年龄>18岁的结核住院患者448例。
- 采用多因素logistic回归分析院内死亡相关因素。
主要发现
- 院内死亡率为16.7%(75/448),粟粒性/播散性结核占13.2%(59/448),在死亡患者中占22.7%(17/75)。
- 入院Karnofsky评分40-10者院内死亡aOR为25.65(95%CI 5.63-116.92),评分70-50者aOR为9.47(95%CI 2.07-43.3)。
- 年龄超过89岁aOR为3.68(95%CI 1.08-12.46),Charlson合并症指数>5者aOR为3.56(95%CI 1.37-9.21)。
- 发生任何医疗保健相关感染aOR为2.95(95%CI 1.35-6.41)。
- 发生导致停用抗结核药物的药物相关不良事件aOR为2.29(95%CI 1.02-5.11),其中7例死亡前未能恢复抗结核治疗。
临床怎么用
- 对入院时功能状态差、高龄、合并症多的结核住院患者应加强院内死亡风险评估。
- 住院期间需重点监测和预防医疗保健相关感染及抗结核药物相关不良事件。
局限性
- 本研究为单中心回顾性队列研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In Japan, most cases of tuberculosis (TB) occur among individuals aged 65 years or older. However, data on in-hospital adverse events (AEs) associated with TB management, especially in high-income nations with an ageing population, are scarce. The present study aimed to scrutinize the current TB unit practices, incidence of in-hospital AEs and predictors of in-hospital mortality. METHODS: This retrospective cohort study was conducted at a tertiary care centre in Tokyo, Japan from 2012 to 2017. Inpatients with the diagnosis of TB and aged >18 years were included. Quality of in-hospital care and factors associated with in-hospital mortality were investigated using multivariate logistic regression analysis. RESULTS: In total, 448 patients were enrolled. The in-hospital mortality rate was 16.7% (75/448). Miliary/disseminated TB was common (59/448, 13.2%), especially in those who died (17/75, 22.7%). Factors independently associated with in-hospital mortality were a low Karnofsky performance status score on admission (score: 40-10, adjusted odds ratio (aOR) 25.65, 95% CI 5.63-116.92 and score: 70-50, aOR 9.47, 95% CI 2.07-43.3), age over 89 years (aOR 3.68, 95% CI 1.08-12.46), Charlson Co-morbidity Index >5 (aOR 3.56, 95% CI 1.37-9.21), development of any health-care-associated infection (aOR 2.95, 95% CI 1.35-6.41), and development of any drug-related AE leading to discontinuation of anti-TB agents (seven patients were unable to resume treatment with anti-TB agents before death) (aOR 2.29, 95% CI 1.02-5.11). CONCLUSIONS: In-hospital AEs (i.e. health-care-associated infection and drug-related AEs), as well as patient-related variables, were associated with in-hospital mortality among TB patients.
引用
- Takamatsu A, Kano Y, Tagashira Y, et al. Current in-hospital management for patients with tuberculosis in a high-income country: a retrospective cohort study. Clin Microbiol Infect. 2021. PMID: 34271181. doi:10.1016/j.cmi.2021.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。